Rapp-Hodgkin syndrome (RHS) is a rare type of autosomal dominant disorder characterized by association of ectodermal dysplasia (ED) with cleft lip/palate. The main features include dry, brittle hair with alopecia in adulthood, dental anomalies (hypodontia, microdontia with delayed eruption, fissured tongue, and retruded maxilla), hypohidrosis, dysplastic nails, and clefting. Palmar-plantar keratoderma is seen frequently. RHS has signs and symptoms that overlap considerably with those of ankyloblepharon-ED-clefting syndrome and ectrodactyly-ED-clefting syndrome. This manuscript discusses a case of RHS, one of the four members in three generations who had ED with variable degree of involvement of hair, teeth, nail, and sweat glands.
The incidence of coronal fractures from traumatic injuries is high in school children and causes serious functional, esthetic and psychological problems. Dentists are confronted on a regular basis with their management. Reattachment of a fractured fragment, though not a new technique, is gaining interest as a treatment option. This is due to its advantages over other techniques and advancements in adhesive dentistry. This manuscript presents a 3-year follow-up of a case of complicated permanent mandibular central incisor fracture (no cases reported in literature), that was successfully treated by fragment reattachment using a fiber-reinforced post and discusses the factors affecting the success of reattachment technique.
How to cite this article
Karthikeyani S, Thirumurthy VR, Bindhoo Y. Reattachment of Fractured Mandibular Incisor using Fiber-reinforced Post in a 12-year-old Patient: A 3-year Follow-up. Int J Prosthodont Restor Dent 2015;5(3):86-89.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.